Prevalence of extended-spectrum β-lactamases in South America
Article first published online: 11 DEC 2007
DOI: 10.1111/j.1469-0691.2007.01869.x
© 2008 The Authors
Issue

Clinical Microbiology and Infection
Special Issue: ESBLs, Forever?
Volume 14, Issue Supplement s1, pages 154–158, January 2008
Additional Information
How to Cite
Villegas, M. V., Kattan, J. N., Quinteros, M. G. and Casellas, J. M. (2008), Prevalence of extended-spectrum β-lactamases in South America. Clinical Microbiology and Infection, 14: 154–158. doi: 10.1111/j.1469-0691.2007.01869.x
Publication History
- Issue published online: 11 DEC 2007
- Article first published online: 11 DEC 2007
- Abstract
- Article
- References
- Cited By
Keywords:
- CTX-M;
- extended-spectrum β-lactamases;
- Pseudomonas Extended Resistance;
- review;
- SHV;
- South America;
- TEM
Abstract
In South American countries, the class A extended-spectrum β-lactamases (ESBLs) so far recognised belong to the CTX-M, Pseudomonas Extended Resistance (PER), SHV and TEM families. ESBL rates in South America are among the highest in the world, probably due to multiple factors. SHV- and TEM-type ESBLs have been frequently encountered, but CTX-M is endemic and widely dominant. PER-type ESBLs seem to be restricted to the southern ‘cone’ of South America. Community-acquired ESBLs are starting to appear.

1469-0691/asset/bannerforeground.jpg?v=1&s=d64312ac8b913a4f04c6e0a755daba751d8d8d8d)